Wolverine Trading, LLC Jazz Pharmaceuticals PLC Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

26 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$100.57 - $116.37 $522,963 - $605,124	-5,200 Reduced 57.14%	3,900 $434,000
Q2 2024 Aug 14, 2024	BUY	$103.94 - $118.98 $634,034 - $725,778	6,100 Added 203.33%	9,100 $971,000
Q1 2024 May 15, 2024	BUY	$115.19 - $132.77 $46,076 - $53,108	400 Added 15.38%	3,000 $361,000
Q4 2023 Feb 14, 2024	SELL	$114.26 - $136.0 $182,816 - $217,600	-1,600 Reduced 38.1%	2,600 $319,000
Q3 2023 Nov 15, 2023	BUY	$122.0 - $145.31 $244,000 - $290,620	2,000 Added 90.91%	4,200 $543,000
Q2 2023 Aug 23, 2023	SELL	$122.5 - $147.16 $159,250 - $191,308	-1,300 Reduced 37.14%	2,200 $272,000
Q1 2023 May 15, 2023	BUY	$133.98 - $160.47 $80,388 - $96,282	600 Added 20.69%	3,500 $507,000
Q4 2022 Feb 14, 2023	BUY	$129.72 - $159.85 $142,692 - $175,835	1,100 Added 61.11%	2,900 $462,000
Q3 2022 Nov 14, 2022	BUY	$126.59 - $161.18 $227,862 - $290,124	1,800 New	1,800 $238,000
Q2 2022 Aug 15, 2022	SELL	$141.59 - $168.66 $991,130 - $1.18 Million	-7,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$129.64 - $160.7 $544,488 - $674,940	-4,200 Reduced 37.5%	7,000 $1.1 Million
Q4 2021 Feb 14, 2022	SELL	$119.87 - $145.67 $167,818 - $203,937	-1,400 Reduced 11.11%	11,200 $1.44 Million
Q3 2021 Nov 12, 2021	SELL	$128.64 - $184.79 $1.02 Million - $1.46 Million	-7,900 Reduced 38.54%	12,600 $1.66 Million
Q2 2021 Aug 06, 2021	BUY	$160.2 - $186.42 $3.28 Million - $3.82 Million	20,500 New	20,500 $3.67 Million
Q1 2021 May 14, 2021	SELL	$150.19 - $173.5 $345,437 - $399,050	-2,300 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$140.71 - $165.05 $1.44 Million - $1.68 Million	-10,200 Reduced 81.6%	2,300 $378,000
Q3 2020 Nov 13, 2020	SELL	$105.46 - $144.13 $73,822 - $100,891	-700 Reduced 5.3%	12,500 $1.75 Million
Q2 2020 Aug 13, 2020	SELL	$95.68 - $121.88 $1.26 Million - $1.61 Million	-13,200 Reduced 50.0%	13,200 $1.45 Million
Q1 2020 May 11, 2020	BUY	$87.74 - $152.74 $2.32 Million - $4.03 Million	26,400 New	26,400 $2.63 Million
Q2 2019 Aug 20, 2019	SELL	$125.55 - $144.48 $2.96 Million - $3.41 Million	-23,600 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$121.81 - $142.95 $2.03 Million - $2.39 Million	16,700 Added 242.03%	23,600 $3.37 Million
Q4 2018 Feb 14, 2019	SELL	$115.94 - $166.74 $1.38 Million - $1.98 Million	-11,900 Reduced 63.3%	6,900 $840,000
Q3 2018 Nov 14, 2018	BUY	$161.01 - $180.57 $1.16 Million - $1.3 Million	7,200 Added 62.07%	18,800 $3.16 Million
Q1 2018 May 15, 2018	BUY	$135.59 - $157.16 $718,627 - $832,948	5,300 Added 84.13%	11,600 $1.75 Million
Q4 2017 Feb 14, 2018	SELL	$131.06 - $150.39 $511,134 - $586,521	-3,900 Reduced 38.24%	6,300 $848,000
Q3 2017 Nov 15, 2017	BUY	$142.62 - $155.6 $1.45 Million - $1.59 Million	10,200	10,200 $1.49 Million

Others Institutions Holding JAZZ

# of Institutions

511

Shares Held

57.8M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.63B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account